In contrast to our in vitro findings, we demonstrated a positive correlation between IGF-II and H19 mRNA expression in the prostate tissue; whilst this was weaker in benign tissue, the stronger positive correlation—seen in malignant tissue—concurred with that of the larger TGCA prostate and breast cancer cohorts. The gene discussed is IGF2; the disease is breast carcinoma.